MyAverix Finance
WAR · Healthcare
Mabion S.A. (MAB)
Biotechnology
Mabion S.A. (MAB) is listed on WAR in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for MAB
P/E ratio
25.00
Mabion S.A. (MAB) — FAQ
What is MAB's P/E ratio?
The price-to-earnings (P/E) ratio for Mabion S.A. (MAB) is 25.00 (data as of 2026-05-24).
Does Mabion S.A. pay a dividend?
Dividend yield is not available in the current snapshot for Mabion S.A. (MAB). Check the MyAverix Finance app for the latest dividend data.
What sector is Mabion S.A. in?
Mabion S.A. (MAB) is classified in the Healthcare sector (Biotechnology industry).
What exchange is MAB listed on?
MAB is listed on WAR.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.